Skip to main content

Wave Life Sciences, Inc.

WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001631574

In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Q3 2024 vs. Q2 2024

How the institutions holding Wave Life Sciences, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of WVE: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1442162+20
Shares95.1M6.76M120.2M+31.9M (+36.2%)
Value$474.4M$33.7M$986.1M+$545.4M (+123.8%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Wave Life Sciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to WVE in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.7,298,423$59.8M0.00%
Siren, L.L.C.5,721,172$46.9M2.35%
Artisan Partners Limited Partnership1,960,470$16.1M0.02%
RTW Investments, LP900,000$7.38M0.11%
Maven Securities LTD850,000$6.97M0.79%
MPM Oncology Impact Management LP624,471$5.12M0.77%
Walleye Capital LLC602,441$4.94M0.05%
Polar Asset Management Partners Inc.486,023$3.99M0.10%
Woodline Partners LP451,813$3.70M0.03%
Baker Bros. Advisors LP344,063$2.82M0.03%
StemPoint Capital LP300,000$2.46M0.74%
Monashee Investment Management LLC260,000$2.13M0.23%
Cubist Systematic Strategies, LLC163,196$1.34M0.02%
Ghisallo Capital Management LLC140,000$1.15M0.06%
Crestline Management, LP135,260$1.11M0.06%
Alyeska Investment Group, L.P.125,000$1.02M0.01%
Renaissance Technologies LLC104,520$857.1K0.00%
Norges Bank100,000$820.0K0.00%
Qube Research & Technologies Ltd68,041$557.9K0.00%
Privium Fund Management B.V.48,834$400.4K0.10%
Corton Capital Inc.40,869$335.1K0.16%
Intech Investment Management LLC23,704$194.4K0.00%
Graham Capital Management, L.P.20,950$171.8K0.01%
Weiss Asset Management LP20,000$164.0K0.00%
XTX Topco Ltd15,334$125.7K0.01%
Tudor Investment Corp Et Al15,202$124.7K0.00%
Brinker Capital Investments, LLC14,941$122.5K0.00%
Orion Portfolio Solutions, LLC14,941$122.5K0.00%
Bayesian Capital Management, LP12,701$104.1K0.01%
Aster Capital Management (DIFC) Ltd12,285$100.7K0.02%
Point72 (DIFC) Ltd11,958$98.1K0.01%
Sandia Investment Management LP5,000$41.0K0.07%
Acadian Asset Management LLC3,500$28.0K0.00%
Sterling Capital Management LLC103$8450.00%
Rothschild Investment LLC60$4920.00%
Capital Performance Advisors LLP13$1070.00%
CWM, LLC17$00.00%

Sold out (17)

Institutions that held Wave Life Sciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held Wave Life Sciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding WVE in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.6,738,735$33.6M
Susquehanna Fundamental Investments, LLC18,744$93.5K